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Abstract 
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections that 
are becoming increasingly difficult to combat because of emerging resistance to all current antibiotic classes. For this, 
study of MRSA isolated from admitted patients were carried out. These strains were separately tested for their sensitivity 
to different antibiotics to know which group of antibiotics are most effective particularly for cases of RIMS, Ranchi. 
Material & Methods: The present study was carried out in the Department of Microbiology, Rajendra Institute of 
Medical Sciences (RIMS), Ranchi clinical isolates of MRSA strains were obtained from admitted patients of RIMS, 
Ranchi. The sources of isolate included pus from infected surgical wounds, infected burn wounds, conjunctival swab, 
aural swab, throat swab, vaginal swab, urine etc for microbiological analysis and antimicrobial sensitivity of MRSA. Disc 
diffusion method was employed. Results: All the 264 cases of staphylococcal species isolated from different clinical 
specimens were subjected to coagulase test. It was observed that out of 264 strains of staphylococci isolated from different 
sites 165 strains (62.5%) were coagulase positive and 99 strains (37.5%) were coagulase negative by tube method. It was 
observed that out of 165 strains of staph. aureus isolated from different clinical samples 64 strains of staph. aureus were 
resistant to methicillin (38.78%). Maximum isolation of MRSA were from pus 38 (51.35%), followed by throat swab 19 
(36.36%), aural swab (14.28%) and conjunctival swab (44.44%). It was observed that out of 165 strains of s. aureus 
isolated only 64 strains were resistant to methicillin. All strains of MRSA were 100% sensitive to Vancomycin & 
linezolid. Similarly 92.3% were sensitive to netilmicin, 89.7% to clindamycin, 82.1% to ciprofloxacin, 74.4% to 
cephotaxime, 69.2% to azithromycin, 56.4% to roxithromycin & clarithromycin, 17.9% to piperacillin/tazobactam. The 
most effective antibiotic against MRSA was vancomycin, linezolid, netilmicin & clindamycin. Conclusion: After 
comparing the effectiveness of antibiotics against MRSA infection it can be concluded that piperacillin/tazobactam, 
clarithromycin, roxithromycin azithromycin, cefotaxime & ciprofloxacin are of little value in treating the MRSA infection. 
They should not be used indiscriminately and in a haphazard manner otherwise increment in emergence of resistant strains 
may not be checked.  
Keywords: Staphylococci, methicillin resistant staphylococcus aureus (MRSA), disc diffusion method,antimicrobial 
sensitivity. 
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Introduction  
 
Methicillin, the first semi-synthetic penicillin 
derivative resistant to hydrolysis by staphylococcal β-
lactamase, was introduced into clinical use for the 
treatment of infections caused by penicillin-
resistant Staphylococcus aureus in 1960. In 1961 there 
were reports from the United Kingdom of S. 
aureus isolates that had acquired resistance to 
methicillin (methicillin-resistant S. aureus, MRSA) [1], 
and MRSA isolates were soon recovered from other 
European countries, and later from Japan, Australia, 
and the United States. MRSA is now a problem in 
hospitals worldwide and is increasingly recovered from 
nursing homes and the community[2]. The methicillin 
resistance gene (mecA) encodes a methicillin-resistant 
penicillin-binding protein that is not present in 
susceptible strains and is believed to have been 
acquired from a distantly related species [3,4].Isolates 
of EMRSA-15 and -16 are commonly resistant to 
erythromycin and ciprofloxacin in addition to β-
lactams, and a study at one affected hospital showed a 
temporal relationship between the rates of MRSA 
infection and the use of macrolides, third-generation 
cephalosporins and fluoroquinolones, suggesting that 
the use of antimicrobials to which an outbreak strain is 
resistant is an important contributory factor for the 
persistence of that strain [5]. At present, healthcare-
associated methicillin-resistant S. aureus (HA-MRSA) 
is associated with significant mortality and morbidity 
(longer hospital stays) and imposes a serious economic 
burden on scarce healthcare resources worldwide 
compared to methicillin-sensitive S. aureus (MSSA) 
[6].The genetic basis of methicillin resistance in S. 
aureus is associated with carriage of a mobile cassette 
of genes known as the staphylococcal cassette 
chromosome mec (SCCmec) [7, 8].  
 
Within this cassette is the mecA gene that is 
responsible for resistance to β-lactams including 
methicillin. The product of mecA is the peptidoglycan 
synthesis enzyme penicillin binding protein (PBP) 2a 
involved in cross-linking of peptidoglycan in the 
bacterial cell wall PBP2a has a lower binding affinity 
for β-lactam antibiotics than the native PBP proteins 
encoded in the core genome of S. aureus. The 
subsequent combination of reduced penicillin-binding 
affinity and increased production of PBP2a accounts 
for the observed resistance to β-lactam antibiotics [9]. 
In India, limited information exists on prevalence and 
drug susceptibility patterns of methicillin-resistant S. 
aureus isolated from clinical samples. The incidence of 
MRSA varies from 25 per cent in western part of 
India to 50 per cent in South India. Community 
acquired MRSA (CA-MRSA) has been increasingly 
reported from India [10]. Since methicillin resistant 
staphylococcus aureus strains are resistant to multiple 
antibiotics, there is possibility of extensive outbreaks 
which may be difficult to control. Early detection of 
methicillin resistant staphylococcus is important from 
patients and hospitals point of view. So knowledge of 
methicillin resistant staphylococcus aureus strain and 
their antimicrobial profile is necessary in selection of 
appropriate treatment for methicillin resistant 
staphylococcus aureus infection. The main objective of 
this study was therefore to determine the prevalence of 
MRSA in patients from selected hospitals in RIMS, 
Ranchi. An evaluation of the susceptibility patterns 
of S. aureus isolates from the selected specimen to 
specific antibiotics was also undertaken. 
 
 
Material and  Methods 
The present study was carried out in the department of 
microbiology, RIMS, Ranchi clinical isolates of 
methicillin resistant staphylococcus aureus strains were 
obtained from admitted patients of RIMS, Ranchi. The 
sources of isolate included pus from infected surgical 
wounds, infected burn wounds, conjunctival swab, 
aural swab, throat swab, vaginal swab, urine etc. The 
patients were at first explained the object of the study 
and the method of obtaining the specimen so that their 
full co-operation could be obtained and written 
informed consent were taken.  
Collection of Specimen  
Pus, conjuctival, aural throat and vaginal swab were 
collected by means of sterile cotton swab sticks. The 
sterile cotton swab sticks were moistened with normal 
saline and rubbed over the infected area taking care not 
to touch anything outside so as to prevent 
contamination. Swabs were then aseptically replaced in 
sterilized test tubes to avoid drying of the material. 
Efforts were made to inoculate the specimen within 
two hours of collection. Primary inoculation was done 
on blood agar. The plates after inoculation were 
incubated at 370C for 24 hours. Midstream samples of 
urine were received in a sterilized vial and inoculated 
on MacConkey agar. The plates were incubated at 370C 
for 24 hours.  
Test for Determining Methicillin Resistance  
Methicillin resistant testing was performed by Kirby 
Bauer’s disc diffusion method using methicillin (5μg) 
or oxacillin (1μg) disc. The suspensions for inoculation 
were prepared from isolated colonies from an overnight 
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growth on nutrient agar plates[11-14]. The growth was 
suspended in 0.5ml of sterile saline. A sterile swab was 
dipped into this suspension and excess if inoculum 
were removed by pressing it against the sides of the 
tube. These swabs were used to inoculate one quarter 
of a Mueller Hinton agar plate supplemented with 5% 
sodium chloride. Methicillin or oxacillin disc were 
applied within 15 min after inoculation. The plates 
were incubated at 350C for 24 hours. The diameter of 
the clear zone around the disc was measured and result 
interpreted as susceptible, moderately susceptible or 
resistant as per recommendations[15-19]Zone of 
inhibition less than 10 mm or any growth within the 
zone of inhibition were indicative of methicillin 
resistance. There are three conventional susceptibility 
testing methods like broth dilution, agar dilution and 
disc diffusion method. In this study disc diffusion 
method using commercially available discs were used. 
Lawn cultures were prepared by flooding the surface of 
the plate with a broth culture of the bacterium. Excess 
inoculum was pipette off. Antibiotic discs were placed 
on the inoculated plates by a fine pointed pair of 
forceps (alcohol flamed and cooled). The discs were 
firmly pressed onto the agar to ensure complete 
contact. The discs were distributed so that they were no 
closer than 15mm from the edge of the Petri dish and 
no two discs were closer than 24 mm from centre to 
centre. Plates were placed in the incubator within 15 
minutes after placing the discs and incubated at 370C 
for 16-18 hours. Following incubation, the diameters of 
the zones of inhibition were measured (including the 
6mm diameter of the disc itself) by a ruler. Results 
were seen according to the zone of inhibition (In 
accordance to performance standards for antimicrobial 
susceptibility Tests, NCCLS) [20,21].  
Results 
Table 1: Number of isolation of staphylococcus sp. from different clinical specimens 
Specimens Number 
Pus & wound 84 
Throat swab 78 
Aural swab 39 
Conjunctival swab 32 
Urine 18 
Vaginal swab 13 
 
Table 2: Results of coagulase test of 264 strains of staphylococci isolated from different clinical specimens 
 Coagulase +VE staph. Coagulase -Ve staph. 
Pus & wound 74 10 
Throat swab 55 23 
Aural swab 21 18 
Conjunctival swab     9 23 
      Urine 2 16 
Vaginal swab 4 9 
All the 264 cases of staphylococcal species isolated from different clinical specimens were subjected to 
coagulase test [Table 1]. It was observed that out of 264 strains of staphylococci isolated from different sites 165 
strains (62.5%) were coagulase positive and 99 strains (37.5%) were coagulase negative by tube method. Out of the 
165 strains of coagulase positive staphylococci maximum isolation was obtained from pus 74 followed by throat 
swab 55, aural swab 21, vaginal 4, conjunctival swab 9 and urine 2 [Table 2].  
 
 
         
 
 
Table 3: Showing drug resistance pattern of MRSA isolated from clinical specimens 
Antimicrobial agent (S) % Susceptible  % Intermediate  % Resistance  
Netilmicin 92.3 2.6 5.1 
Vancomycin 100 - - 
Clindamycin 89.7 - 10.3 
Linezolid 100 - - 
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Piperacillin/ Tazobactam 17.9 10.3 71.8 
Roxithromycin 56.4 23.1 20.5 
Cephotaxime 74.4 7.7 17.9 
Ciprofloxacin 82.1 5.1 12.8 
Azithromycin 69.2 7.7 23.1 
Clarithromycin 56.4 23.1 20.5 
 
 
Figure 1: Showing drug resistance pattern of MRSA isolated from clinical specimens 
 
Table 4: Susceptibility of clinical isolates of MRSA from pus (n=38) 
Antimicrobial agent (S) % Susceptible  % Resistance  
Netilmicin 95.7 4.3 
Vancomycin 100 - 
Clindamycin 90.5 9.5 
Linezolid 100 - 
Piperacillin/ Tazobactam 20.2 79.80 
Roxithromycin 50.8 49.2 
Cephotaxime 71.1 28.9 
Ciprofloxacin 79.9 20.1 
Azithromycin 63.2 36.8 
Clarithromycin 50.8 49.2 
 
Table 5: Susceptibility of clinical isolates of MRSA from throat swab (n=19) 
Antimicrobial agent (S) % Susceptible  % Resistance  
Netilmicin 97.4 2.6 
Vancomycin 100 - 
Clindamycin 92.7 7.3 
Linezolid 100 - 
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Piperacillin/ Tazobactam 23.2 76.8 
Roxithromycin 48.5 51.5 
Cephotaxime 72 28 
Ciprofloxacin 80.1 19.9 
Azithromycin 59.3 40.7 
Clarithromycin 48.5 51.5 
 
 
Table 6: Susceptibility of clinical isolates of MRSA from conjunctival swab (n=4) 
Antimicrobial agent (S) % Susceptible  % Resistance  
Netilmicin 62 38 
Vancomycin 100 - 
Clindamycin 97.6 2.4 
Linezolid 100 - 
Piperacillin/ Tazobactam 6.8 93.2 
Roxithromycin 14.8 85.2 
Cephotaxime 38 62 
Ciprofloxacin 43.2 56.8 
Azithromycin 19.9 80.1 
Clarithromycin 14.8 85.2 
 
Maximum isolation of MRSA were from pus 38 
(51.35%), followed by throat swab 19 (36.36%), aural 
swab (14.28%) and conjunctival swab (44.44%). It was 
observed that out of 165 strains of staph. aureus 
isolated only 64 strains were resistant to methicillin. 
All strains of MRSA were 100% sensitive to 
vancomycin & linezolid. Similarly 92.3% were 
sensitive to netilmicin, 89.7% to clindamycin, 82.1% to 
ciprofloxacin, 74.4% to cephotaxime, 69.2% to 
azithromycin, 56.4% to roxithromycin & 
clarithromycin, 17.9% to piperacillin/tazobactam. The 
most effective antibiotic against MRSA was 
vancomycin, linezolid, netilmicin & clindamycin. In 
the present study all 64 strains of MRSA showed 100% 
sensitivity to vancomycin & linezolid, followed by 
92.3% to netilmicin and 89.7% to clindamycin. All 
MRSA strains were 71.8% resistant to 
piperacillin/tazobactam, followed by 23.1% to 
azithromycin, 20.5% to clarithromycin and 
roxithromycin, 17.9% to cephotaxime & 12.8% to 
ciprofloxacin [Table 3-6/Fig.1]. 
 
Discussion 
The present work is “study of methicillin resistance 
staphylococcus aureus isolated from patient admitted in 
RIMS and testing their sensitivity to antimicrobial 
drugs”. Samples were collected from different sources 
such as pus, throat, ear, conjunctiva, vagina, urine etc. 
The pathogenic strains of staphylococcus were studied 
for their resistance to methicillin on Mueller Hinton 
agar supplemented with 5 percent sodium chloride 
using oxacillin or methicillin disc. Recent sensitivity 
pattern of methicillin resistance staphylococcus aureus 
was studied against the available newer antibiotics. So 
knowledge of the methicillin resistant staphylococcus 
aureus strains and their sensitivity pattern will help in 
proper treatment of such patients. In the present study, 
264 strains of staphylococci isolated from different 
clinical samples were subjected to coagulase test. Out 
of which 165 strains (62.5%) were coagulase positive 
staphylococci. Study of coagulase positive 
staphylococci is being compared here. From the above 
observation, it is apparent that in the present study (165 
strains (62.5%) produced coagulase enzyme and 
remaining 99 strains (37.5%) were coagulase negative 
by tube method 160 strains (60.6%) were coagulase 
positive by slide method). This figure correlated will 
with the positive staphylocci and 39.64% coagulase 
negative staphylococci were observed. 
Table 7:Study of coagulase positive staphylococcus aureus in different clinical samples  
Year 1999 2008 2009 
Specimen Deepak et al [13] Anuradha et al [14] Present study 
Pus 88.19% 72% 88% 
Throat Swab 70.5% 73.12% 70% 
Aural Swab 78% 55.56% 54% 
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Conjunctival Swab 33% 27.27% 28% 
Urine 12.5% 15.6% 11% 
Vaginal Swab 33%  28.57%  31% 
In the present study, the rate of occurrence of staph. aureus in pus was (88%), in urine (11%) and in vaginal 
swab (31%) this figure correlated will with the study of pathogenic staphylococci by Deepak et al (1999) [13] 
showing rate of occurrence of staph. aureus in pus (88.19%), in urine (12.5%) and in vaginal swab (33%). It was 
observed that out of 264 strains of staphylococci isolated from different clinical samples, 165 strains of 
staphylococci were coagulase positive (62.5%) and 99 strains (37.5%) were coagulase negative. Out of 165 strains 
of staph. aureus isolates, 64 strains of staph. aureus were resistant to methicillin (38.78%).  
 
Table 8: high incidence of MRSA among Staph. aureus 
Year Author Incidence of MRSA 
1998  Mehta et al [15] 31.8%-36.5% 
1997 C. Udaya Shanker [16] 20% 
2001  Majumdar et al [17]  23.6%  
2003  Anuradha et al [14]  54.8%  
2004 Quereshi [18] 35.3%  
2006  Rajadurai pandi [19] 31.1%  
2006  Srinivasan [20] 33.3%  
2009 Present study 38.78%  
 
The above study correlated well with the study of 
Mehta et al [15] who observed incidence of MRSA to 
range from 31.8% to 36.5%, followed by Quereshi et al 
[18] who observed incidence of MRSA to be 35.3%, 
and study of Srinivasan [20] who observed incidence 
of MRSA to be 33.3%. In the present study, maximum 
isolation of MRSA were from pus (51.35%) which 
correlated well with study of Anuradha et al [14] 
showing MRSA isolation in pus (52.5%) followed by 
study of Rajadurai pandi et al [19] who observed 
MRSA isolation in pus (33.6%). In the present study, 
isolation of MRSA from throat swab were (36.36%) 
which correlated well with study of Rajadurai pandi 
[19] showing MRSA isolation in throat swab (35.7%) 
followed by study of Mehta [15] who observed MRSA 
isolation in throat swab (28.36%). In the present study, 
isolation on MRSA from conjunctival swab were 
(44.44%) which correlated well with study of 
Rajadurai pandi [19] showing isolation of MRSA from 
conjunctival swab (40%). In the present study, isolation 
of MRSA from aural swab were (14.28%) which 
correlated well with study of Rajadurai pandi [19] 
showing isolation of MRSA from aural swab (14%). 
Study by Indian Network for Surveillance of 
Antimicrobial Resistance (INSAR) group, India 
showed that antibiotic susceptibility testing data for 
erythromycin, clindamycin, co-trimoxazole, genta-
micin, vancomycin and linezolid were compiled.  
There was no resistance documented against 
vancomycin and linezolid. Resistance to antibiotics 
amongst the MRSA isolates was more than that in 
methicillin sensitive S. aureus (MSSA) (P<0.001) 
[10].  
 
Antibiotic Sensitivity Pattern of MRSA  
In the present work out of 165 strains of pathogenic 
staphylococci isolated form different clinical samples 
64 strains of staph. aureus were resistant to methicillin. 
These 64 strains of MRSA were studied for their 
susceptibility to following drugs - netilmicin, 
vancomycin, clindamycin, linezolid, 
piperacillin/tazobactam, roxithromycin, cephotaxime, 
ciprofloxacin, azithromycin and clarithromycin. 
 
 
 
Table 9: Comparative study of sensitivity pattern of MRSA by various workers 
International Journal of Health and Clinical Research, 2020;3(3):12-20                e-ISSN: 2590-3241, p-ISSN: 2590-325X                         
                                                             
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Boipai et al                     International Journal of Health and Clinical Research, 2020; 3(3):12-20 
www.ijhcr.com                              
        18 
 
 
 
In the present study all 64 strains of MRSA showed 
100% sensitivity to vancomycin & linezolid, followed 
by 92.3% to netilmicin and 89.7% to clindamycin. All 
MRSA strains were 71.8% resistant to 
piperacillin/tazobactam, followed by 23.1% to 
azithromycin, 20.5% to clarithromycin and 
roxithromycin, 17.9% to cephotaxime & 12.8% to 
ciprofloxacin. In the present study all MRSA strains 
showed 100% sensitivity to vancomycin and linezolid 
which correlated well with the study of Mehta et al 
(1996) [15] followed by Anupurba et al (2003) [21], 
Rajaduraipandi (2006) [19] and Qureshi et al (2004) 
[18] showing 100% sensitivity to above drugs [Table 
9].  
In the present study MRSA strains showed 
92.3% sensitivity to netilmicin which correlated well 
with the study of Rajaduraipandi [19] showing 92% 
sensitivity to netilmicin, followed by study of Mehta et 
al showing 57% sensitivity to netilmicin and study of 
Anupurba et al [21] showing 52.5% sensitivity to 
netilmicin. In the present study all MRSA strains 
showed 89.7% sensitivity to clindamycin which 
correlates well with the study of Srinivasan et al [20] 
who observed 94.6% sensitivity to clindamycin. In the 
present study MRSA strains showed 82.1% sensitivity 
to ciprofloxacin which correlated well with the study of 
C. Udayashankar [16] showing 95.8% sensitivity to 
ciprofloxacin, followed by study of Rajaduraipandi 
[19] showing 82% sensitivity to ciprofloxacin. In the 
present study MRSA strains showed 74.4% sensitivity 
to cephotaxime which correlated well with the study of 
Rajaduraipandi [19] showing 74% sensitivity to 
cephotaxime. In the present study all MRSA strains 
showed 17.9% sensitivity to piperacillin/tazobactam, 
followed 56.4% to roxithromycin, 69.2% to 
azithromycin and 56.4% to clarithromycin. From the 
above discussions it is clear that most potent 
antistaphylococcal agent used in MRSA is vancomycin 
and linezolid. Though clindamycin, netilmicin, 
ciprofloxacin and cephotaxime is also effective. 
Piperacillin/tazobactam, roxithromycin, azithromycin 
& clarithromycin are less effective in cases of MRSA. 
Unscientific and random use of antibiotics has led to 
emergence of resistant strains of pathogenic 
staphylococci to multiple antibiotics commonly used in 
the hospital. So, for the early recovery of the patients, 
the easiest way is to know the most virulent strains of 
staphylococci occurring in the hospital. For this, ideal 
way is to do the bacteriophage typing, there by 
knowing which phage type is most frequent. Since 
phage typing is not possible in most of the institution in 
our country hence isolated stains are subjected for a 
relative study of the pathogenecity. Later on sensitivity 
test of the strains to commonly used antibiotic in the 
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hospital is done. Thus the most effective antibiotic 
against MRSA is vancomycin. Here in this study we 
see that vancomycin is most potent and effective drug 
against MRSA and sensitive to 100% strains but as the 
drug is costly and associated with toxicity it is out of 
reach for the poor people who come to government 
hospital. So, use of vancomycin is limited to the 
treatment of serious life threatening MRSA infection. 
As an alternative to vancomycin, linezolid, netilmicin, 
clindamycin, ciprofloxacin & cephotaxime can be used 
for treating MRSA infection. Thus from foregoing 
discussions it is obvious that in the treatment of MRSA 
infection the proper way is to have the sensitivity test 
and then to give antibiotics. Vancomycin should be 
given only when other antibiotics have proven to be 
ineffective to a great extent. 
 
Conclusion 
It was observed that out of 165 strains of s. aureus 
isolated only 64 strains were resistant to methicillin. 
All strains of MRSA were 100% sensitive to 
vancomycin & linezolid. Similarly 92.3% were 
sensitive to netilmicin, 89.7% to clindamycin, 82.1% to 
ciprofloxacin, 74.4% to cephotaxime, 69.2% to 
azithromycin, 56.4% to roxithromycin & 
clarithromycin, 17.9% to Piperacillin/Tazobactam. The 
most effective antibiotic against MRSA was 
vancomycin, linezolid, netilmicin & clindamycin. 
Methicillin-resistant Staphylococcus aureus (MRSA) 
has been identified as one of the major risk pathogens 
associated with the development of antimicrobial 
resistance (AMR). The emergence of AMR in S. 
aureus is well documented and the species has proven 
particularly adept at evolving resistance in the face of 
new antibiotic challenges.  
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